Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (111-120 of 310) with videos related to

Pageof 31
Sort By:
Molecular Cancer Research : MCR|October 19, 2018
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the ProstateHabiba Elfandy, Joshua Armenia, Filippo Pederzoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
Copy number alteration burden predicts prostate cancer relapseHaley Hieronymus, Nikolaus Schultz, Anuradha Gopalan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2012
A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletionsWen Xue, Thomas Kitzing, Stephanie Roessler, et al.
Journal of the National Cancer Institute|May 3, 2024
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated diseaseFergus Keane, Joanne F Chou, Henry Walch, et al.
JCI Insight|May 17, 2016
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolismAnup Sood, Alexandra M Miller, Edi Brogi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2024
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal CancerEmily Harrold, Fergus Keane, Henry Walch, et al.
Radiology|August 3, 2021
Patterns of Metastatic Disease in Patients with Cancer Derived from Natural Language Processing of Structured CT Radiology Reports over a 10-year PeriodRichard K G Do, Kaelan Lupton, Pamela I Causa Andrieu, et al.
European Urology|September 19, 2022
Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate CancerEthan S Barnett, Nikolaus Schultz, Konrad H Stopsack, et al.
Nature|March 17, 2016
Deletions linked to TP53 loss drive cancer through p53-independent mechanismsYu Liu, Chong Chen, Zhengmin Xu, et al.
Nature|June 15, 2017
ERF mutations reveal a balance of ETS factors controlling prostate oncogenesisRohit Bose, Wouter R Karthaus, Joshua Armenia, et al.
Pageof 31

Showing results (111-120 of 310) with videos related to

Sort By:
Pageof 31
Molecular Cancer Research : MCR|October 19, 2018
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the ProstateHabiba Elfandy, Joshua Armenia, Filippo Pederzoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
Copy number alteration burden predicts prostate cancer relapseHaley Hieronymus, Nikolaus Schultz, Anuradha Gopalan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2012
A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletionsWen Xue, Thomas Kitzing, Stephanie Roessler, et al.
Journal of the National Cancer Institute|May 3, 2024
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated diseaseFergus Keane, Joanne F Chou, Henry Walch, et al.
JCI Insight|May 17, 2016
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolismAnup Sood, Alexandra M Miller, Edi Brogi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2024
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal CancerEmily Harrold, Fergus Keane, Henry Walch, et al.
Radiology|August 3, 2021
Patterns of Metastatic Disease in Patients with Cancer Derived from Natural Language Processing of Structured CT Radiology Reports over a 10-year PeriodRichard K G Do, Kaelan Lupton, Pamela I Causa Andrieu, et al.
European Urology|September 19, 2022
Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate CancerEthan S Barnett, Nikolaus Schultz, Konrad H Stopsack, et al.
Nature|March 17, 2016
Deletions linked to TP53 loss drive cancer through p53-independent mechanismsYu Liu, Chong Chen, Zhengmin Xu, et al.
Nature|June 15, 2017
ERF mutations reveal a balance of ETS factors controlling prostate oncogenesisRohit Bose, Wouter R Karthaus, Joshua Armenia, et al.
Pageof 31